Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

[MRI-parameters of frontal lobes in schizophrenia: correlations with the level of autoantibodies to nerve growth factor in the blood serum].

Shcherbakova IV, Efanova NN, Orlova VA, Kliushnik TP, Voskresenskaia NI, Gubskiĭ AV, Kupriianov DA, Ganisheva TK, Anisimov NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(3):44-6. Russian.

PMID:
19365391
2.

[Dynamics of immunological and clinical parameters in the treatment of childhood schizophrenia].

Kliushnik TP, Kalinina MA, Sarmanova ZV, Otman IN, Kozlovskaia GV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(6):46-9. Russian.

PMID:
19672227
3.

[Changes in the level of autoantibodies to the nerve growth factor in the blood serum of schizophrenia patients].

Kliushnik TP, Danilovskaia EV, Vatolkina OE, Turkova IL, Tsutsul'kovskaia MIa, Orlova VA, Kaleda VG.

Zh Nevrol Psikhiatr Im S S Korsakova. 1998;98(3):32-4. Russian.

PMID:
9575628
4.

Leukocyte elastase and autoantibodies to nerve growth factor in the acute phase of schizophrenia and their relationship to symptomatology.

Shcherbakova IV, Siryachenko TM, Mazaeva NA, Kaleda VG, Krasnolobova SA, Klyushnik TP.

World J Biol Psychiatry. 2004 Jul;5(3):143-8.

PMID:
15346538
5.

[Nerve growth factor auto-antibodies in children with various forms of mental dysontogenesis and in schizophrenia high risk group].

Kozlovskaia GV, Kliushnik TP, Goriunova AV, Turkova IL, Kalinina MA, Sergienko NS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(3):50-2. Russian.

PMID:
10758649
6.

[An elevation in the level of autoantibodies to nerve-growth factor in the blood serum of schizophrenic children].

Bashina VM, Kozlova IA, Kliushnik TP, Simashkova NV, Danilovskaia EV, Gorbachevskaia NL, Turkova IL, Iakupova LP, Grachev VV.

Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(1):47-51. Russian.

PMID:
9163249
7.

[Correlation between the level of autoantibodies to nerve growth factor and clinical features of schizophrenia in children].

Kliushnik TP, Turkova IL, Danilovskaia EV, Kozlova IA, Bashina VM, Simashkova NV, Vabishchevich NK.

Zh Nevrol Psikhiatr Im S S Korsakova. 1999;99(1):49-51. Russian. No abstract available.

PMID:
11530461
8.

[A state of innate and adaptive immunity in children with schizophrenia and in the high-risk group for the disease].

Shcherbakova IV, Kozlovskaia GV, Kalinina MA, Kliushnik TP.

Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(11):45-9. Russian.

PMID:
16329635
9.

Brain-directed autoantibodies levels in the serum of Rett syndrome patients.

Klushnik TP, Gratchev VV, Belichenko PV.

Brain Dev. 2001 Dec;23 Suppl 1:S113-7.

PMID:
11738855
10.

The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia.

Xiong P, Zeng Y, Wan J, Xiaohan DH, Tan D, Lu J, Xu F, Li HY, Zhu Z, Ma M.

Psychiatry Res. 2011 Aug 30;189(1):72-6. doi: 10.1016/j.psychres.2010.12.017. Epub 2011 Jan 31.

PMID:
21277636
11.

[Nerve growth factor auto-antibodies in the sera of mothers of schizophrenic children and children from high risk group].

Zakharenko OM, Kliushnik TP, Kozlova IA, Kozlovskaia GV, Danilovskaia EV, Bashina VM, Simashkova VM, Goriunova AV, Kalinina MA.

Zh Nevrol Psikhiatr Im S S Korsakova. 1999;99(3):44-6. Russian.

PMID:
10205843
12.

Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment.

Ajami A, Hosseini SH, Taghipour M, Khalilian A.

Scand J Immunol. 2014 Jul;80(1):36-42. doi: 10.1111/sji.12158.

13.

Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.

He ZL, Deng W, Li ML, Chen ZF, Collier DA, Ma X, Li T.

Early Interv Psychiatry. 2012 May;6(2):166-75. doi: 10.1111/j.1751-7893.2011.00291.x. Epub 2011 Sep 23.

PMID:
21951785
14.

Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients--part II: adult subjects.

Spivak B, Schechtman M, Schonherz-Pine Y, Blumensohn R, Mostovoy S, Amital D, Deckmann M, Weizman A, Shinitzky M.

Neuropsychobiology. 2009;60(1):49-54. doi: 10.1159/000235802. Epub 2009 Sep 1.

PMID:
19729973
15.

Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia.

Xiong P, Zeng Y, Zhu Z, Tan D, Xu F, Lu J, Wan J, Ma M.

Schizophr Res. 2010 Jun;119(1-3):34-9. doi: 10.1016/j.schres.2010.02.1063. Epub 2010 Mar 29.

PMID:
20303241
16.

Changes in the serum levels of autoantibody to nerve growth factor in patients with schizophrenia.

Klyushnik TP, Danilovskaya EV, Vatolkina OE, Turkova IL, Tsutsul'kovskaya MYa, Orlova VA, Kaleda VG.

Neurosci Behav Physiol. 1999 May-Jun;29(3):355-7.

PMID:
10493550
17.

[Neurospecific proteins and autoantibodies in serum of patients with acute ischemic stroke].

Kamchatov PR, Ruleva NIu, Dugin SF, Buriachkovskaia LI, Chugunov AV, Mikhaĭlova NA, Basse DA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(5 Suppl 2):69-72. Russian.

PMID:
19894304
18.
19.

An MRI study of structural variations in schizophrenia using deformation field morphometry.

Yoon U, Lee JM, Kwon JS, Kim HP, Shin YW, Ha TH, Kim IY, Chang KH, Kim SI.

Psychiatry Res. 2006 Mar 31;146(2):171-7. Epub 2006 Feb 28.

PMID:
16510267
20.

Differential relationship of frontal pole and whole brain volumetric measures with age in neuroleptic-naïve schizophrenia and healthy subjects.

John JP, Burgess PW, Yashavantha BS, Shakeel MK, Halahalli HN, Jain S.

Schizophr Res. 2009 Apr;109(1-3):148-58. doi: 10.1016/j.schres.2008.12.019. Epub 2009 Jan 29.

PMID:
19185466

Supplemental Content

Support Center